低氧诱导因子1α(HIF1α)重组蛋白-蛋白质/抗原/多肽-试剂-生物在线
低氧诱导因子1α(HIF1α)重组蛋白

低氧诱导因子1α(HIF1α)重组蛋白

商家询价

产品名称: 低氧诱导因子1α(HIF1α)重组蛋白

英文名称: Recombinant Hypoxia Inducible Factor 1 Alpha (HIF1a)

产品编号: YB798Rb011

产品价格: 0

产品产地: 中国/美国

品牌商标: 钰博生物/Ybscience

更新时间: 2023-08-17T10:29:50

使用范围: null

上海钰博生物科技有限公司
  • 联系人 : 陈环环
  • 地址 : 上海市沪闵路6088号龙之梦大厦8楼806室
  • 邮编 : 200612
  • 所在区域 : 上海
  • 电话 : 183****2235
  • 传真 : 021-60514606
  • 邮箱 : shybio@126.com

 低氧诱导因子1α(HIF1α)重组蛋白

YB798Rb011
Recombinant Hypoxia Inducible Factor 1 Alpha (HIF1a)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
低氧诱导因子1α(HIF1α)重组蛋白9th Edition (Revised in Jul, 2013)
[ PROPERTIES ]
Residues: Arg575~Asn826 (Accession # Q16665),
with two N-terminal Tags, His-tag and GST-tag. Host: E. coli
Subcellular Location: Cytoplasm. Nucleus. Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
pH7.4, containing 5% sucrose, 0.01% sarcosyl.
Predicted isoelectric point: 6.0
Predicted Molecular Mass: 59.4kDa
低氧诱导因子1α(HIF1α)重组蛋白Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
[ SEQUENCES ]
The target protein is fused with two N-terminal Tags, His-tag and GST-tag, its
低氧诱导因子1α(HIF1α)重组蛋白sequence is listed below.
MSPILGYWKI KGLVQPTRLL LEYLEEKYEE HLYERDEGDK WRNKKFELGL EFPNLPYYID
GDVKLTQSMA IIRYIADKHN MLGGCPKERA EISMLEGAVL DIRYGVSRIA YSKDFETLKV
DFLSKLPEML KMFEDRLCHK TYLNGDHVTH PDFMLYDALD VVLYMDPMCL DAFPKLVCFK
KRIEAIPQID KYLKSSKYIA WPLQGWQATF GGGDHPPKSD GSTSGSGHHH HHHSAGLVPR
GSTAIGMKET AAAKFERQHM DSPDLGTLEV LFQGPLGSEF-RSFDQL SPLESSSASP
ESASPQSTVT VFQQTQIQEP TANATTTTAT TDELKTVTKD RMEDIKILIA SPSPTHIHKE
TTSATSSPYR DTQSRTASPN RAGKGVIEQT EKSHPRSPNV LSVALSQRTT VPEEELNPKI
LA L Q NA Q RK R KM E H D GS L F Q AV G I G T L L Q Q P D D HA AT T S L SW K RV K G CK S
SEQNGMEQKT IILIPSDLAC RLLGQSMDES GLPQLTSYDC EVNAPIQGSR NLLQGEELLR
ALDQVN
[ REFERENCES ]
1. Harrison H., et al. (2013) Cancer Res. 73:1420-1433. 2. Erpolat O.P., et al. (2013) Strahlenther Onkol 189:147-154. 3. Morten K.J., et al. (2013) J. Pathol. 229:755-764. 4. Strauss E., et al. (2012) Prz. Lek. 69:744-749.